Duo Oncology Alternatives & Competitors
12 companies similar to Duo Oncology — Nanomedicines as the foundation of cancer medicine. Platform chemistry designed...
Companies similar to Duo Oncology
RayzeBio
Targeted innovative radiopharmaceuticals for cancer
San Diego, United States
Cytimmune Sciences
Developing safer more effective therapies that can attack tumors on multiple fronts simult...
Rockville, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Glycyx
Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...
San Francisco, United Sta...
Rival Readout
Competing with Duo Oncology? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Onchilles Pharma
Developing drug candidates that have the potential to be broadly effective against a wide...
San Diego, United States
Massive Bio
AI-driven system connecting cancer patients to clinical trials in real time. Industrializi...
Istanbul, Turkey
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Cambridge, United States
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
About Duo Oncology
Duo Oncology, founded in 2020 by oncologists, is making strides in the Biotechnology and Pharmaceutical industries. Headquartered in the United States, the company is focusing on developing tumor-penetrating nanomedicines, which it claims will upgrade the foundations of cancer medicine. At the heart of their innovation...
Development of Nanomedicines, Cancer Therapy Innovation, Drug Approval Processes, Platform for Drug Delivery
Cancer Patients, Oncologists, Pharmaceutical Companies
Nanomedicine, Oncology, Tumor-penetration, Prodrug Chemistry, Nanoparticle Technology, Cancer Treatment, Pharmaceutical Development, Drug Delivery Systems, Patient Outcomes, Tumor-targeting, University Collaboration, Medical Oncology, Research Partnerships, Lean Pharma Business
B2B, D2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Duo Oncology: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Duo Oncology on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
